SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-054140
Filing Date
2020-10-07
Accepted
2020-10-07 16:48:08
Documents
2
Period of Report
2020-10-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1691
2 POA DOCUMENT poa.txt EX-24.3_940788 3851
  Complete submission text file 0001209191-20-054140.txt   7071
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Issuer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CARA THERAPEUTICS, INC. 4 STAMFORD PLAZA, 107 ELM STREET STAMFORD CT 06902
Business Address
Reilly Thomas Charles (Reporting) CIK: 0001827590 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36279 | Film No.: 201229499